These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10480285)

  • 1. Effect of recombinant human erythropoietin in preterm infants.
    Krallis N; Cholevas V; Mavridis A; Georgiou I; Bourantas K; Andronikou S
    Eur J Haematol; 1999 Aug; 63(2):71-6. PubMed ID: 10480285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of very low birth weight infants after erythropoietin treatment to prevent anemia of prematurity.
    Soubasi V; Kremenopoulos G; Diamanti E; Tsantali C; Sarafidis K; Tsakiris D
    J Pediatr; 1995 Aug; 127(2):291-7. PubMed ID: 7636658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin (rHuEPO) administration to premature infants for the treatment of their anemia.
    Giannakopoulou C; Bolonaki I; Stiakaki E; Dimitriou H; Galanaki H; Hatzidaki E; Kalmanti M
    Pediatr Hematol Oncol; 1998; 15(1):37-43. PubMed ID: 9509504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of erythropoietin and its effects on blood lactate and 2, 3-diphosphoglycerate in premature neonates.
    Soubasi V; Kremenopoulos G; Tsantali C; Savopoulou P; Mussafiris C; Dimitriou M
    Biol Neonate; 2000 Nov; 78(4):281-7. PubMed ID: 11093007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in red cell phosphate metabolism of preterm and fullterm infants with perinatal problems during their first month of life.
    Cholevas V; Challa A; Lapatsanis PD; Andronikou S
    Eur J Pediatr; 2008 Feb; 167(2):211-8. PubMed ID: 17458560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3 diphosphoglycerate-haemoglobin binding in uraemic patients treated with erythropoietin. A 31P-nuclear magnetic resonance study.
    Monti JP; Brunet P; Baz M; Klinkmann H; Berland Y; Merzouk T; Elsen R; Crevat A
    Nephrol Dial Transplant; 1993; 8(3):223-6. PubMed ID: 8385288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.
    Case DC; Bukowski RM; Carey RW; Fishkin EH; Henry DH; Jacobson RJ; Jones SE; Keller AM; Kugler JW; Nichols CR
    J Natl Cancer Inst; 1993 May; 85(10):801-6. PubMed ID: 8487324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
    Lauterbach R; Kachlik P; Pawlik D; Bajorek I
    Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients.
    Tarng DC; Huang TP
    Nephrol Dial Transplant; 2002 Jun; 17(6):1063-9. PubMed ID: 12032198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum transferrin receptor, ferritin, and reticulocyte maturity indices during the first year of life in 'large' preterm infants.
    Schiza V; Giapros V; Pantou K; Theocharis P; Challa A; Andronikou S
    Eur J Haematol; 2007 Nov; 79(5):439-46. PubMed ID: 17916083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red cell glycolytic intermediates and adenosine triphosphate in preterm infants on the first day of life.
    Travis SF; Kumar SP; Sacks LM; Gillmer P; Delivoria-Papadopoulos M
    Pediatr Res; 1985 Jan; 19(1):117-21. PubMed ID: 3969302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum transferrin receptor concentration is not indicative of erythropoietic activity in chronic hemodialysis patients with poor response to recombinant human erythropoietin.
    Hou CC; Wu SC; Wu SC; Yang WC; Huang TP; Ng YY
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Aug; 61(8):456-62. PubMed ID: 9745161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high doses of human recombinant erythropoietin on the need for blood transfusions in preterm infants.
    Carnielli V; Montini G; Da Riol R; Dall'Amico R; Cantarutti F
    J Pediatr; 1992 Jul; 121(1):98-102. PubMed ID: 1625101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of recombinant human erythropoietin in treating the anemia of prematurity.
    Wang TS; Lee CC; Deng HH; Lin JT; Chang JS; Lin ST
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):121-7. PubMed ID: 7793277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of rHuEpo on blood transfusions in preterm infants after the fifteenth day of life.
    Testa M; Reali A; Copula M; Pinna B; Birocchi F; Pisu C; Chiappe F
    Pediatr Hematol Oncol; 1998; 15(5):415-20. PubMed ID: 9783307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.